Evidence map›Paper›PMID 36358182›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model.

Sergey V Valiulin, Andrey A Onischuk, Anatoly M Baklanov, Sergey N Dubtsov, Galina G Dultseva, Sergey V An'kov, Tatiana G Tolstikova, Sergey N Belogorodtsev, Yakov Sh Schwartz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sergey V ValiulinVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Andrey A OnischukVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Anatoly M BaklanovVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Sergey N DubtsovVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Galina G DultsevaVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Sergey V An'kovVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Tatiana G TolstikovaVoevodsky Institute of Chemical Kinetics & Combustion, Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Sergey N BelogorodtsevNovosibirsk Tuberculosis Research Institute, Novosibirsk, 630040 Novosibirsk, Russia.
Yakov Sh SchwartzNovosibirsk Tuberculosis Research Institute, Novosibirsk, 630040 Novosibirsk, Russia.
Institute of Chemical Kinetics and Combustion · RUNovosibirsk Tuberculosis Research Institute · RUNovosibirsk Institute of Organic Chemistry · RU

Funding

Russian Science Foundation 19-73-10143, https://rscf.ru/en/project/19-73-10143/
6 · The paper itself

Abstract

The aerosol inhalation delivery of isoniazid in mice was investigated, and the specific activity of the aerosol form of isoniazid was studied with the mouse model of tuberculosis infection, the

Indexed as

anti-tuberculous agenthistologic analysisinhalationisoniazidmicerecovery rate

Identifiers

PMID36358182
PMCPMC9686539
OpenAlexW4307922058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.